| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 58,297,462 | 70,782,158 | 49,919,000 | | Cost of Revenue | 36,729,235 | 43,672,739 | 58,246,000 | | | Gross Profit | 21,568,228 | 27,109,419 | (8,327,000) | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 10,672,542 | 12,746,694 | 8,574,000 | | Non Recurring | 8,385,670 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 2,510,016 | 14,362,725 | (16,901,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,370,728) | 3,595,170 | 374,000 | | Earnings Before Interest And Taxes | 5,953,826 | 17,957,895 | (16,578,000) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 5,953,826 | 17,957,895 | (16,578,000) | | Income Tax Expense | 1,576,222 | 4,479,000 | (7,978,000) | | Minority Interest |
-
|
-
| (254,000) | | | | Net Income From Continuing Ops | 4,377,604 | 13,478,896 | (8,854,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 340,000 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 4,377,604 | 13,478,896 | (8,514,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,377,604 | $13,478,896 | ($8,514,000) |
|
0.29% Nasdaq 
Income Statement
